Skip to content

ESPIDEC: what changed

BE 0896.802.612NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€227,994
2024 · €200,421+€27,573
Equity
€1.4m
2024 · €1.2m+€207,994
Cash
€134,391
2024 · €216,211-€81,821
Balance sheet total
€2.3m
2024 · €2.2m+€113,721

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€290,092

    up €290,092 (+109%), from €265,751 to €555,843

    of which Other amounts receivable: +€272,031

  • Tangible fixed assets -€103,879

    down €103,879 (-9.9%), from €1.1m to €950,572

    of which Plant, machinery and equipment: -€76,490

  • Cash -€81,821

    down €81,821 (-37.8%), from €216,211 to €134,391

    mainly Receivables within one year (-€290,092) and Debts after one year (-€127,208)

  • Stocks and contracts +€40,231

    up €40,231 (+6.5%), from €616,351 to €656,581

  • Current investments -€30,000

    no longer reported in 2025; in 2024 it stood at €30,000

Equity and liabilities
  • Profit (loss) carried forward +€207,994

    up €207,994 (+17.9%), from €1.2m to €1.4m

  • Debts after one year -€127,208

    down €127,208 (-18.0%), from €707,584 to €580,376

  • Short-term financial debts +€39,380

    first reported in 2025, at €39,380

Income statement
  • Gross operating margin +€26,030

    up €26,030 (+4.0%), from €645,853 to €671,883

  • Taxes +€10,494

    up €10,494 (+17.0%), from €61,730 to €72,224

  • Depreciation -€6,907

    down €6,907 (-5.9%), from €117,254 to €110,347

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €200,421
Gross operating margin +€26,030
Staff costs +€195
Depreciation +€6,907
Other operating charges -€22
Financial income +€651
Financial charges +€4,307
Taxes -€10,494
Result 2025 €227,994
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€1,216
Investment +€23,531
Financing -€104,135
Cash 2024 €216,211
Net result for the year +€227,994
Depreciation +€110,347
Stocks and contracts -€40,231
Receivables within one year -€290,092
Deferred charges and accrued income +€903
Trade debts -€9,155
Tax, wage and social debts +€2,410
Other debts -€4,627
Accrued charges and deferred income +€1,233
Investment in fixed assets (net) -€6,469
Current investments +€30,000
Debts after one year -€127,208
Current portion of long-term debt +€3,693
Short-term financial debts +€39,380
Contributions, distributions and other -€20,000
Cash 2025 €134,391
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,184,112 €2,297,832 +€113,721 +5.2%
Fixed assets 21/28 €1,054,451 €950,572 -€103,879 -9.9%
Tangible fixed assets 22/27 €1,054,451 €950,572 -€103,879 -9.9%
Land and buildings 22 €442,503 €417,470 -€25,033 -5.7%
Plant, machinery and equipment 23 €578,276 €501,786 -€76,490 -13.2%
Furniture and vehicles 24 €33,673 €31,317 -€2,356 -7.0%
Current assets 29/58 €1,129,660 €1,347,260 +€217,599 +19.3%
Stocks and contracts in progress 3 €616,351 €656,581 +€40,231 +6.5%
Stocks 30/36 €616,351 €656,581 +€40,231 +6.5%
Amounts receivable within one year 40/41 €265,751 €555,843 +€290,092 +109%
Trade receivables 40 €117,132 €135,192 +€18,060 +15.4%
Other amounts receivable 41 €148,619 €420,651 +€272,031 +183%
Current investments 50/53 €30,000 - -€30,000
Cash at bank and in hand 54/58 €216,211 €134,391 -€81,821 -37.8%
Deferred charges and accrued income 490/1 €1,348 €445 -€903 -67.0%
Total equity and liabilities 10/49 €2,184,112 €2,297,832 +€113,721 +5.2%
Equity 10/15 €1,171,397 €1,379,391 +€207,994 +17.8%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,860 €1,860 = 0.0%
Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
Reserves not available under the articles 1311 €1,860 €1,860 = 0.0%
Profit (loss) carried forward 14 €1,163,337 €1,371,331 +€207,994 +17.9%
Amounts payable 17/49 €1,012,715 €918,441 -€94,273 -9.3%
Amounts payable after more than one year 17 €707,584 €580,376 -€127,208 -18.0%
Financial debts 170/4 €707,584 €580,376 -€127,208 -18.0%
Amounts payable within one year 42/48 €305,131 €336,832 +€31,701 +10.4%
Current portion of amounts payable after more than one year 42 €133,960 €137,653 +€3,693 +2.8%
Financial debts 43 - €39,380 +€39,380
Credit institutions 430/8 - €39,380 +€39,380
Trade debts 44 €85,093 €75,938 -€9,155 -10.8%
Suppliers 440/4 €85,093 €75,938 -€9,155 -10.8%
Taxes, remuneration and social security 45 €47,185 €49,596 +€2,410 +5.1%
Taxes 450/3 €20,214 €20,306 +€92 +0.5%
Remuneration and social security 454/9 €26,971 €29,290 +€2,318 +8.6%
Other amounts payable 47/48 €38,893 €34,266 -€4,627 -11.9%
Accrued charges and deferred income 492/3 - €1,233 +€1,233
Remuneration, social security and pensions 62 €242,363 €242,168 -€195 -0.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €117,254 €110,347 -€6,907 -5.9%
Other operating charges 640/8 €5 €27 +€22 +442%
Gross operating margin 9900 €645,853 €671,883 +€26,030 +4.0%
Operating profit (loss) 9901 €286,231 €319,340 +€33,110 +11.6%
Financial income 75/76B - €651 +€651
Recurring financial income 75 - €651 +€651
Financial charges 65/66B €24,080 €19,773 -€4,307 -17.9%
Recurring financial charges 65 €24,080 €19,773 -€4,307 -17.9%
Profit (loss) for the period before taxes 9903 €262,150 €300,218 +€38,068 +14.5%
Income taxes 67/77 €61,730 €72,224 +€10,494 +17.0%
Profit (loss) for the period 9904 €200,421 €227,994 +€27,573 +13.8%
Profit (loss) for the period to be appropriated 9905 €200,421 €227,994 +€27,573 +13.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€1.3m to €1.6m

Midpoint €1.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.4m
Capitalised earnings €1.3m to €1.8m
Indication €1.3m to €1.6m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€1,379,391
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.4m

Capitalised earnings

net result for the year (9904)
2025
€227,994
2024
€200,421
2023
€122,884
2022
€282,176
excluding non-recurring income and charges
€260,160
2021
€271,273
Average result
€183,766
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.3m / €1.5m / €1.8m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.